OSF HOLY FAMILY MED CTR — History
CCN 141318 | 3-year financial timeline | COVID resilience: 71/100
🛡️ Public data only — no PHI permitted on this instance.
$44M
Latest Revenue (FY2022)
+22.7%
Revenue CAGR (3yr)
29.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $29M | $38M | $44M | +17.3% | +22.7% |
| Operating Expenses | $27M | $29M | $31M | +5.7% | +7.3% |
| Operating Margin | 8.0% | 22.0% | 29.6% | +34.9% | +92.2% |
| Net Income | $2M | $8M | $13M | +58.2% | +135.7% |
| Licensed Beds | 23 | 19 | 19 | +0.0% | -9.1% |
| Total Patient Days | 990 | 1,512 | 1,661 | +9.9% | +29.5% |
| Medicare Day % | 70% | 58% | 61% | +4.2% | -6.7% |
| Medicaid Day % | 2% | 2% | 1% | -40.6% | -33.1% |
COVID Impact & Recovery
Resilience Score: 71/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +50.5% ($29M → $44M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+22.7%
This Hospital
+7.6%
State Avg
Latest Margin
29.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $52M | 40.4% |
| FY2024 (proj) | $59M | 51.2% |
| FY2025 (proj) | $67M | 62.0% |